UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Annals of oncology, 2009-04, Vol.20 (4), p.666-673

2009

Volltextzugriff (PDF)

Associations of various blood pressure parameters with functional outcomes after endovascular thrombectomy in acute ischaemic stroke

European journal of neurology, 2019-07, Vol.26 (7), p.1019-1027

2019

Volltextzugriff (PDF)

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

Annals of oncology, 2019-02, Vol.30 (2), p.250-258

2019

Volltextzugriff (PDF)

Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer

British journal of cancer, 2014-07, Vol.111 (3), p.497-505

2014

Volltextzugriff (PDF)

Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum

British journal of cancer, 2012-04, Vol.106 (9), p.1469-1474

2012

Volltextzugriff (PDF)

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

British journal of cancer, 2009-03, Vol.100 (6), p.894-900

2009

Volltextzugriff (PDF)

Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma

Annals of oncology, 2007-05, Vol.18 (5), p.886-891

2007

Volltextzugriff (PDF)

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer

Oncoimmunology, 2019-02, Vol.8 (2), p.e1544442-e1544442

2019

Volltextzugriff (PDF)

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours

British journal of cancer, 2013-09, Vol.109 (6), p.1414-1419

2013

Volltextzugriff (PDF)

Autologous adipose tissue-derived stem cells for the treatment of complex perianal fistulas not associated with Crohn’s disease: a phase II clinical trial for safety and efficacy

Techniques in coloproctology, 2017-05, Vol.21 (5), p.345-353

2017

Volltextzugriff (PDF)

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial

Annals of oncology, 2021-03, Vol.32 (3), p.368-374

2021

Volltextzugriff (PDF)

Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells

Oncogene, 2013-07, Vol.32 (28), p.3339-3349

2013

Volltextzugriff (PDF)

A comparative study on the short-term clinicopathologic outcomes of laparoscopic surgery versus conventional open surgery for transverse colon cancer

Surgical endoscopy, 2009-08, Vol.23 (8), p.1812-1817

2009

Volltextzugriff (PDF)

Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer

Annals of oncology, 2010-06, Vol.21 (6), p.1285-1289

2010

Volltextzugriff (PDF)

Brain metastases from colorectal cancer: the role of surgical resection in selected patients

Colorectal disease, 2012-07, Vol.14 (7), p.e378-e385

2012

Volltextzugriff (PDF)

Innovative personalized medicine in gastric cancer: time to move forward

Clinical genetics, 2014-07, Vol.86 (1), p.37-43

2014

Volltextzugriff (PDF)

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

British journal of cancer, 2005-05, Vol.92 (10), p.1850-1854

2005

Volltextzugriff (PDF)

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

Annals of oncology, 2018-04, Vol.29 (4), p.1037-1048

2018

Volltextzugriff (PDF)

Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer

Annals of oncology, 2019-03, Vol.30 (3), p.424-430

2019

Volltextzugriff (PDF)

CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?

Annals of oncology, 2001-03, Vol.12 (3), p.349-352

2001

Volltextzugriff (PDF)

Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the Cause of Silent Cerebral Infarction in Healthy Subjects)

European journal of neurology, 2013-02, Vol.20 (2), p.353-360

2013

Volltextzugriff (PDF)

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

British journal of cancer, 2015-11, Vol.113 (10), p.1421-1426

2015

Volltextzugriff (PDF)

Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

British journal of cancer, 2004-07, Vol.91 (1), p.11-17

2004

Volltextzugriff (PDF)

Altered neural circuit for working memory before and after symptom provocation in patients with obsessive-compulsive disorder

Acta psychiatrica Scandinavica, 2006-05, Vol.113 (5), p.420-429

2006

Volltextzugriff (PDF)

Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition

Annals of oncology, 2017-03, Vol.28 (3), p.547-554

2017

Volltextzugriff (PDF)

1 – 25 von 2.492

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.187)
Mit Volltextzugriff
(2.197)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.908)
Life Sciences & Biomedicine
(1.055)
Humans
(672)
Technology
(551)
Physical Sciences
(533)
Male
(480)
Biological And Medical Sciences
(470)
Female
(440)
Physics
(363)
Medical Sciences
(350)
Animals
(347)
Exact Sciences And Technology
(339)
Engineering
(307)
Middle Aged
(297)
Adult
(292)
Applied Sciences
(230)
Materials Science
(200)
Aged
(198)
Chemistry
(169)
Engineering, Electrical & Electronic
(168)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in patients with advanced gastric cancer: a randomised phase III noninferiority trial

Associations of various blood pressure parameters with functional outcomes after endovascular thrombectomy in acute ischaemic stroke

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer

Randomised phase II trial of docetaxel and sunitinib in patients with metastatic gastric cancer who were previously treated with fluoropyrimidine and platinum

Trastuzumab treatment improves brain metastasis outcomes through control and durable prolongation of systemic extracranial disease in HER2-overexpressing breast cancer patients

Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma

PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer

Phase II study of pazopanib monotherapy in metastatic gastroenteropancreatic neuroendocrine tumours

Autologous adipose tissue-derived stem cells for the treatment of complex perianal fistulas not associated with Crohn’s disease: a phase II clinical trial for safety and efficacy

A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial

Transcriptional regulation of MDR-1 by HOXC6 in multidrug-resistant cells

A comparative study on the short-term clinicopathologic outcomes of laparoscopic surgery versus conventional open surgery for transverse colon cancer

Outcomes after repeated resection for recurrent pulmonary metastases from colorectal cancer

Brain metastases from colorectal cancer: the role of surgical resection in selected patients

Innovative personalized medicine in gastric cancer: time to move forward

Salvage chemotherapy with irinotecan, 5-fluorouracil and leucovorin for taxane- and cisplatin-refractory, metastatic gastric cancer

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients

Epigenomic promoter alterations predict for benefit from immune checkpoint inhibition in metastatic gastric cancer

CHOP followed by involved field radiation: Is it optimal for localized nasal natural killer/T-cell lymphoma?

Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the Cause of Silent Cerebral Infarction in Healthy Subjects)

A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer

Patterns of failure in gastric carcinoma after D2 gastrectomy and chemoradiotherapy: a radiation oncologist's view

Altered neural circuit for working memory before and after symptom provocation in patients with obsessive-compulsive disorder

Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition

Suchergebnisse filtern